Delivery Order SPE2DB20D3103-SPE2DB25FN0F9
- Not listed
- This federal contract award, valued at $5,486.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract has a ceiling value of $8,529.87 and is a Firm Fixed Price Delivery Order that runs through December 16, 2024. The contract does not have a set-aside designation, indicating it was...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S for the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,285.98 and an ultimate completion date of May 23, 2024. It is a firm fixed-price delivery order contract with no set-aside requirements. Amerisourcebergen Drug Corp is the prime contractor, and this award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product used for the treatment of opioid overdose. The contract has a ceiling value of $1,497.79 and a completion date of April 17, 2023. This contract is not designated as a set-aside and was awarded as a firm fixed-price Delivery Order....
- This federal contract award, valued at $2,890.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of 4,562,866,740 units of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract has an ultimate completion date of November 21, 2023 and utilizes a Firm Fixed Price pricing type....
- This federal contract award, with ID SPE2DB20D2014|SPE2DB23FC08U, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,982.22 Firm Fixed Price Delivery Order is for the supply of 4560761747 NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The contract has an ultimate completion date of May 1, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract has a ceiling value of $1,449.12 and is a Firm Fixed Price Delivery Order, with a completion date of December 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, with ID SPE2DB22D3501|SPE2DB24FTZ80, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, which has a ceiling value of $1,804.20, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract is a Firm Fixed Price Delivery Order with a completion date of January 2, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The contract, valued at $3,456.03, is a Firm Fixed Price Delivery Order with a period of performance through February 28, 2024. This contract is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,623.05 Firm Fixed Price Delivery Order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract has an ultimate completion date of April 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FN0F9Delivery Order
This federal contract award, identified as SPE2DB20D3103|SPE2DB25FN0F9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract has a ceiling value of $33,313.51 and is a Firm Fixed Price Delivery Order, with a completion date of March 12, 2025. Amerisourcebergen Drug Corp is the prime contractor on this award and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.3k | 3/11/25 |